Effect of melatonin supplementation in treatment of patients with Parkinson's disease
Phase 2
- Conditions
- Parkinson's disease.Parkinson's disease
- Registration Number
- IRCT20170513033941N29
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with Parkinson' disease.
Individuals aged 50 to 90 years.
Exclusion Criteria
Unwillingness to cooperate
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hs-CRP. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: ELISA test.
- Secondary Outcome Measures
Name Time Method